Leo Cancer Care
PrivateLast Round
Series D
Jul 8, 2026
Est. Valuation
$425M
Total Funding Raised
$130.34M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Leo Cancer Care operates in Healthcare & Life Sciences and is based in Crawley. Its latest recorded funding round was a Series D round in July 2026.
Leo Cancer Care is a medical technology company that develops integrated upright patient positioning and imaging systems to streamline radiation therapy.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Leo Cancer Care Comparables
Compare Leo Cancer Care with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| P-Cure Ltd | 86% | |
| Ehmet Health | 76% | |
| Mevion Medical Systems | 74% |
For institutional investors. Book with your work email.
Leo Cancer Care Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Jul 8, 2026 | ||||
| VC Round | Sep 24, 2025 | ||||
| Series C | Jun 11, 2024 | ||||
| Series C | Sep 24, 2023 | ||||
| Series B | Jul 20, 2021 | ||||
Grant | Mar 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Leo Cancer Care Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bioshore Capital Partners | Series D |
| Eventide Funds | Series D |
| Gaingels | Series B |
| Junson Capital | Series B |
| Device of Tomorrow Capital | Series B |
| Serra Ventures | Series B, Series D |
| EDBI | Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 8, 2026
$65M round led by Yu Galaxy
- Jun 23, 2026
Monthly visitors grew 52% MoM, from 4.2K to 6.4K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventNov 11, 2026
Leo Cancer Care Ltd attends the second annual Upright RT Summit in Massachusetts on Nov 11th '26, where the upright radiotherapy community discusses clinical practice alongside ASTRO.
- is_developingNov 5, 2026
Leo Cancer Care Ltd is developing a series of pediatric patient information booklets to help children and families understand upright radiotherapy, with reviews from clinical partners and its Voices of Experience Network.
- is_developingSep 27, 2026
At ASTRO 2025, Leo Cancer Care Ltd is developing a dedicated fixed-beam photon platform, subject to regulatory clearance, that integrates upright patient positioning, imaging, and a fixed photon beam.
- launchesSep 27, 2026
On Sep 27th '26 in Massachusetts, Leo Cancer Care Ltd brings the Upright Platform into clinical use as a beam-agnostic upright radiotherapy platform cleared for use with any radiation beam.
- partners_withSep 16, 2026
On Sep 16th '26, Leo Cancer Care Ltd and Imperial announce a research collaboration to investigate workflows for real-time tumour tracking and radiation dose verification in upright radiotherapy.
For institutional investors. Book with your work email.
Leo Cancer Care Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Leo Cancer Care's valuation, stock price, and market status.
Is Leo Cancer Care a public or private company?
Leo Cancer Care is a private company.
What is the current stock price of Leo Cancer Care?
Leo Cancer Care is a private company, so its shares have no public market price. Caplight tracks Leo Cancer Care's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Leo Cancer Care worth (valuation)?
Leo Cancer Care's valuation is estimated at $425.0M based on funding round data.
Can I buy Leo Cancer Care stock?
Leo Cancer Care shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Leo Cancer Care's last funding round?
Leo Cancer Care's most recent funding round was Series D on July 8, 2026.
Who are the main investors in Leo Cancer Care?
Key investors in Leo Cancer Care include Catalio Capital Management, Pureland Global Venture, Alumni Ventures, Yu Galaxy, Macmillan Cancer Support.
Will Leo Cancer Care IPO soon?
No public IPO plans have been announced for Leo Cancer Care.
How can I track Leo Cancer Care secondary market activity?
Caplight tracks bids, offers, and trades in Leo Cancer Care's shares on secondary markets.